Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

IM Cannabis (IMCC) Interest Expenses (2020 - 2025)

Historic Interest Expenses for IM Cannabis (IMCC) over the last 6 years, with Q3 2025 value amounting to -$495442.3.

  • IM Cannabis' Interest Expenses fell 33324.43% to -$495442.3 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year decrease of 10175.42%. This contributed to the annual value of -$3.3 million for FY2024, which is 1988.89% down from last year.
  • According to the latest figures from Q3 2025, IM Cannabis' Interest Expenses is -$495442.3, which was down 33324.43% from -$1.3 million recorded in Q2 2025.
  • IM Cannabis' Interest Expenses' 5-year high stood at $1.2 million during Q4 2021, with a 5-year trough of -$1.7 million in Q2 2022.
  • In the last 5 years, IM Cannabis' Interest Expenses had a median value of -$541750.4 in 2025 and averaged -$648028.0.
  • Per our database at Business Quant, IM Cannabis' Interest Expenses surged by 11083.99% in 2021 and then plummeted by 33958.66% in 2022.
  • Quarter analysis of 5 years shows IM Cannabis' Interest Expenses stood at $1.2 million in 2021, then plummeted by 246.96% to -$1.7 million in 2022, then increased by 8.67% to -$1.6 million in 2023, then increased by 14.08% to -$1.4 million in 2024, then skyrocketed by 63.36% to -$495442.3 in 2025.
  • Its Interest Expenses stands at -$495442.3 for Q3 2025, versus -$1.3 million for Q2 2025 and -$1.4 million for Q4 2024.